Processing

NEWS IN BRIEF

Nimble leaves Roche to commercialize chemical synthesis technology

09-May-2019 By Maggie Lynch

Nimble Therapeutics spun out from parent company Roche to commercialize its chemical synthesis technology for drug discovery and development.

Merck ‘evaluating global footprint’ with $1.2bn manufacturing restructure

07-May-2019 By Ben Hargreaves

Merck continues its multi-year restructuring process with a program that could cost up to $1.2bn and has a provisional end date of 2023.

Sharp ‘future proofs’ manufacturing with facility investment

06-May-2019 By Maggie Lynch

Sharp invests $21m to meet growing demand by expanding its capacity for packaging services at its Allentown, PA campus.

Novo Nordisk on track for 100% renewable energy use by 2020

30-Apr-2019 By Ben Hargreaves

The Danish company is set to use only renewable electricity to run its global production facilities by 2020, after an investment of $70m in a 672-acre solar panel installation.

Catalent invests $14m in softgel manufacturing facility

30-Apr-2019 By Maggie Lynch

Catalent’s Germany-based facility to expand to meet demand of animal-free products after $14m investment.

Catalent installing new tableting, encapsulation equipment as part of $40m investment

29-Apr-2019 By Melissa Fassbender

Catalent is installing new equipment to increase its formulation capabilities and capacity to manufacture controlled-release tablets and capsules.

GSK ramps up Shingrix production with $100m investment

25-Apr-2019 By Ben Hargreaves

GSK announces that it will spend $100m to expand production capacity for components of Shingrix, amid a US market where demand outstrips supply of its shingles vaccine.

NEWS IN BRIEF

MS Pharma acquires Genepharm, expands chronic disease portfolio

23-Apr-2019 By Vassia Barba

Jordan-based MS Pharma announces the acquisition of the Greek generic manufacturer Genepharm, aiming to add cardiovascular, CNS and oncology products to its portfolio.

Colorcon expands coating portfolio with DuPont’s Aquacoat

22-Apr-2019 By Vassia Barba

Colorcon adds DuPont’s Aquacoat technology, held in CR Alliance’s portfolio, whilst planning to transition existing customers over to the company.

‘Flexibility, agility and quality assurance’: Advantages of continuous manufacturing

10-Apr-2019 By Maggie Lynch

Continuous manufacturing gives agility to the supply chain that the industry did not previously have, according to a principal scientist Janssen.

UPDATED

GSK and AZ partner with CPI for continuous manufacturing facility

08-Apr-2019 By Ben Hargreaves

UK pharma giants, GSK and AstraZeneca, collaborate with CPI to build a continuous wet granulation manufacturing facility for oral solid dosage drugs.

NEWS IN BRIEF

Janssen issues layoffs ahead of California plant closure

08-Apr-2019 By Staff Reporter

Almost 50 employees will have their employment terminated at Janssen’s California site as the site prepares to close.

Antibióticos do Brasil expands Sao Paolo site by 25%

02-Apr-2019 By Ben Hargreaves

The Brazil-headquartered antibiotics company announces that it has invested in two new buildings, a few years after running into regulatory trouble due to non-compliance with cGMP.

Roche to close Rio de Janeiro facility as Brazil market weakens

28-Mar-2019 By Ben Hargreaves

The Switzerland headquartered company will close its Rio de Janeiro manufacturing facility over the next four to five years.

How to tackle a sticky issue

27-Mar-2019 By Ben Hargreaves

Sticking is one of the most common issues that is faced in the manufacture of tablets, and may become a more pressing issue once continuous manufacturing is broadly adopted, suggests I Holland’s R&D manager.